LBH589

Search structure
Status: Phase 2
Entry Type: Small molecule
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Myelodysplastic Syndromes; Preleukemia; Syndrome Phase 2 ClinicalTrials
Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Lymphoma; Lymphoma, Mantle-Cell Phase 2 ClinicalTrials
Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid Phase 2/Phase 3 ClinicalTrials
Waldenstrom Macroglobulinemia Phase 2 ClinicalTrials
Glioma Phase 1 ClinicalTrials
Carcinoma; Carcinoma, Renal Cell; Kidney Neoplasms Phase 2 ClinicalTrials
Multiple Myeloma; Neoplasms, Plasma Cell Phase 1 ClinicalTrials
Neoplasms Phase 1 ClinicalTrials
Polycythemia; Polycythemia Vera; Primary Myelofibrosis; Thrombocythemia, Essential; Thrombocytosis Phase 1/Phase 2 ClinicalTrials
Colorectal Neoplasms Phase 2 ClinicalTrials
Glioma Phase 1/Phase 2 ClinicalTrials
Neoplasms Phase 1 ClinicalTrials
Lymphoma; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse Phase 2 ClinicalTrials
Multiple Myeloma; Neoplasms, Plasma Cell Phase 1 ClinicalTrials
Graft vs Host Disease Phase 2 ClinicalTrials
Neoplasms Phase 1 ClinicalTrials
Prostatic Neoplasms Phase 1 ClinicalTrials
Multiple Myeloma Phase 1/Phase 2 ClinicalTrials
Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Preleukemia; Syndrome Phase 1/Phase 2 ClinicalTrials
Breast Neoplasms Phase 1 ClinicalTrials
Lymphoma; Lymphoma, T-Cell; Lymphoma, T-Cell, Cutaneous Phase 2/Phase 3 ClinicalTrials
Melanoma Phase 1 ClinicalTrials
Lymphoma; Lymphoma, Non-Hodgkin Phase 1 ClinicalTrials
Lymphoma; Lymphoma, Non-Hodgkin Phase 1 ClinicalTrials
Myelodysplastic Syndromes; Preleukemia; Syndrome Phase 2 ClinicalTrials
Carcinoma, Non-Small-Cell Lung; Mesothelioma Phase 1 ClinicalTrials
Lymphoma; Lymphoma, T-Cell; Lymphoma, T-Cell, Cutaneous Phase 1 ClinicalTrials
Prostatic Neoplasms Phase 1 ClinicalTrials
Thyroid Diseases; Thyroid Neoplasms Phase 2 ClinicalTrials
Lymphoma; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse Phase 2 ClinicalTrials
Multiple Myeloma; Neoplasms, Plasma Cell Phase 2 ClinicalTrials
CONTENTS